Cargando…
Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024945/ https://www.ncbi.nlm.nih.gov/pubmed/24851020 http://dx.doi.org/10.3346/jkms.2014.29.5.652 |
_version_ | 1782316702317412352 |
---|---|
author | Lee, Soo Young Han, Seung Beom Bae, E Young Kim, Jong-Hyun Kang, Jin Han Park, Yeon-Joon Ma, Sang Hyuk |
author_facet | Lee, Soo Young Han, Seung Beom Bae, E Young Kim, Jong-Hyun Kang, Jin Han Park, Yeon-Joon Ma, Sang Hyuk |
author_sort | Lee, Soo Young |
collection | PubMed |
description | This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and anti-pertussis toxin (PT) IgG titers were measured using a commercial ELISA kit. We compared the mean anti-PT IgG titers and seroprevalence of pertussis of the six age groups: 11-20, 21-30, 31-40, 41-50, 51-60, and ≥ 61 yr. A total of 1,192 subjects were enrolled. The mean anti-PT IgG titer and pertussis seroprevalence were 35.53 ± 62.91 EU/mL and 41.4%, respectively. The mean anti-PT IgG titers and seroprevalence were not significantly different between the age groups. However, the seroprevalence in individuals 51 yr of age or older was significantly higher than in individuals younger than 51 yr (46.5% vs 39.1%, P = 0.017). Based on these results, a new pertussis prevention strategy is necessary for older adults. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-4024945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | The Korean Academy of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-40249452014-05-21 Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G Lee, Soo Young Han, Seung Beom Bae, E Young Kim, Jong-Hyun Kang, Jin Han Park, Yeon-Joon Ma, Sang Hyuk J Korean Med Sci Original Article This study was conducted to evaluate age-specific seroprevalence of pertussis in Korea and to formulate a strategy to prevent and reduce the incidence of pertussis. Residual serum samples of healthy adolescents and adults 11 yr of age or older were collected between July 2012 and December 2012, and anti-pertussis toxin (PT) IgG titers were measured using a commercial ELISA kit. We compared the mean anti-PT IgG titers and seroprevalence of pertussis of the six age groups: 11-20, 21-30, 31-40, 41-50, 51-60, and ≥ 61 yr. A total of 1,192 subjects were enrolled. The mean anti-PT IgG titer and pertussis seroprevalence were 35.53 ± 62.91 EU/mL and 41.4%, respectively. The mean anti-PT IgG titers and seroprevalence were not significantly different between the age groups. However, the seroprevalence in individuals 51 yr of age or older was significantly higher than in individuals younger than 51 yr (46.5% vs 39.1%, P = 0.017). Based on these results, a new pertussis prevention strategy is necessary for older adults. GRAPHICAL ABSTRACT: [Image: see text] The Korean Academy of Medical Sciences 2014-05 2014-04-25 /pmc/articles/PMC4024945/ /pubmed/24851020 http://dx.doi.org/10.3346/jkms.2014.29.5.652 Text en © 2014 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Lee, Soo Young Han, Seung Beom Bae, E Young Kim, Jong-Hyun Kang, Jin Han Park, Yeon-Joon Ma, Sang Hyuk Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G |
title | Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G |
title_full | Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G |
title_fullStr | Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G |
title_full_unstemmed | Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G |
title_short | Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G |
title_sort | pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin g |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024945/ https://www.ncbi.nlm.nih.gov/pubmed/24851020 http://dx.doi.org/10.3346/jkms.2014.29.5.652 |
work_keys_str_mv | AT leesooyoung pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling AT hanseungbeom pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling AT baeeyoung pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling AT kimjonghyun pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling AT kangjinhan pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling AT parkyeonjoon pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling AT masanghyuk pertussisseroprevalenceinkoreanadolescentsandadultsusingantipertussistoxinimmunoglobuling |